CN103804395B - 头孢噻肟钠n,n-二甲基甲酰胺溶剂化合物及制备方法 - Google Patents
头孢噻肟钠n,n-二甲基甲酰胺溶剂化合物及制备方法 Download PDFInfo
- Publication number
- CN103804395B CN103804395B CN201410020280.2A CN201410020280A CN103804395B CN 103804395 B CN103804395 B CN 103804395B CN 201410020280 A CN201410020280 A CN 201410020280A CN 103804395 B CN103804395 B CN 103804395B
- Authority
- CN
- China
- Prior art keywords
- solvated compounds
- dmf
- cefotaxime
- mole
- cefotaxime sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410020280.2A CN103804395B (zh) | 2014-01-16 | 2014-01-16 | 头孢噻肟钠n,n-二甲基甲酰胺溶剂化合物及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410020280.2A CN103804395B (zh) | 2014-01-16 | 2014-01-16 | 头孢噻肟钠n,n-二甲基甲酰胺溶剂化合物及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103804395A CN103804395A (zh) | 2014-05-21 |
CN103804395B true CN103804395B (zh) | 2015-12-02 |
Family
ID=50701826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410020280.2A Active CN103804395B (zh) | 2014-01-16 | 2014-01-16 | 头孢噻肟钠n,n-二甲基甲酰胺溶剂化合物及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103804395B (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0088847B1 (en) * | 1981-11-13 | 1986-02-26 | Glaxo Group Limited | Thiazole derivatives and their use in the manufacture of beta-lactam antibiotics |
CN1634932A (zh) * | 2004-10-27 | 2005-07-06 | 山东瑞阳制药有限公司 | 头孢噻肟钠的制备工艺 |
WO2011042776A1 (en) * | 2009-10-09 | 2011-04-14 | Nectar Lifesciences Ltd. | Process for preparation of cefotaxime acid and pharmaceutically acceptable salt thereof |
CN102584854A (zh) * | 2012-02-02 | 2012-07-18 | 瑞阳制药有限公司 | 头孢噻肟钠无水结晶的制备工艺 |
CN103275101A (zh) * | 2013-05-17 | 2013-09-04 | 天津大学 | 制备头孢噻肟钠晶体的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005040175A2 (en) * | 2003-10-22 | 2005-05-06 | Ranbaxy Laboratories Limited | Process for the preparation of cephem carboxylic acids |
-
2014
- 2014-01-16 CN CN201410020280.2A patent/CN103804395B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0088847B1 (en) * | 1981-11-13 | 1986-02-26 | Glaxo Group Limited | Thiazole derivatives and their use in the manufacture of beta-lactam antibiotics |
CN1634932A (zh) * | 2004-10-27 | 2005-07-06 | 山东瑞阳制药有限公司 | 头孢噻肟钠的制备工艺 |
WO2011042776A1 (en) * | 2009-10-09 | 2011-04-14 | Nectar Lifesciences Ltd. | Process for preparation of cefotaxime acid and pharmaceutically acceptable salt thereof |
CN102584854A (zh) * | 2012-02-02 | 2012-07-18 | 瑞阳制药有限公司 | 头孢噻肟钠无水结晶的制备工艺 |
CN103275101A (zh) * | 2013-05-17 | 2013-09-04 | 天津大学 | 制备头孢噻肟钠晶体的方法 |
Non-Patent Citations (3)
Title |
---|
Solubility of Sodium Cefotaxime in Different Solvents;Haitao Zhang,et al.,;《Journal of Chemical & Engineering Data》;20070308;第52卷(第3期);第982-985页 * |
头孢噻肟钠结晶工艺的研究;赵洪娥,等,;《河北化工》;20130228;第36卷(第2期);第9-10、16页 * |
溶析结晶研究进展;鲍颖,等,;《化学工业与工程》;20041130;第21卷(第6期);第438-443页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103804395A (zh) | 2014-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102875574A (zh) | 头孢曲松钠晶型及其制备方法 | |
US20180273526A1 (en) | Crystal form of pyrroloquinoline quinone sodium salt and preparation method and use thereof | |
US9012628B2 (en) | Crystalline form of ertapenem sodium and preparation method therefor | |
CN102875531B (zh) | 一种(r)-兰索拉唑无水晶型及其制备方法 | |
WO2017140074A1 (zh) | 盐酸头孢甲肟新晶型及制剂 | |
CN103804395B (zh) | 头孢噻肟钠n,n-二甲基甲酰胺溶剂化合物及制备方法 | |
CN102516261A (zh) | 一种头孢地尼的制备方法 | |
CN103755723A (zh) | 一种利福平i晶型的制备方法 | |
Meenatchi et al. | Crystal growth, structure and characterization of o-hydroxybenzoic acid single crystals: Solvent effects | |
CN101768105A (zh) | 丁酸氯维地平的晶型 | |
CN101906109A (zh) | 一种头孢呋辛钠的制备方法 | |
CN106317080A (zh) | 一种采用耦合结晶技术制备的头孢他啶化合物及其制剂 | |
CN103172530B (zh) | 一种托芬那酸的制备方法 | |
CN102382072A (zh) | 一种d-环丝氨酸的精制方法 | |
JP5827684B2 (ja) | 2−[3−シアノ−4−(2−i−ブトキシ)フェニル]−4−メチル−5−チアゾール−カルボン酸(フェブキソスタット)の結晶形Aを調製するための方法 | |
CN102391259A (zh) | 一种硝呋太尔化合物及其制法 | |
CN102746323B (zh) | 一种头孢呋辛酸的新晶型及其结晶制备方法 | |
CN106279298B (zh) | 一种手性d-酒石酸四十八核铜簇合物及其绿色合成方法 | |
CN101823980B (zh) | 大颗粒盐酸土霉素的制备方法 | |
CA2961819C (en) | L-proline compound of sodium-glucose cotransporter 2 inhibitor, and monohydrate and crystal of l-proline compound | |
CN102659644B (zh) | 2-氨基乙磺酸的晶型及制备工艺 | |
CN103554137B (zh) | 一种头孢地尼微粉的制备方法 | |
JP2017031126A (ja) | ピロロキノリンキノン結晶の製造方法 | |
CN109734724A (zh) | 一种哌拉西林酸的结晶方法 | |
CN102875532A (zh) | 一种(r)-兰索拉唑异丙胺盐及其晶型和制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Bao Ying Inventor after: Chen Wei Inventor after: Xie Chuang Inventor after: Gao Zhenguo Inventor after: Hou Baohong Inventor after: Zhang Suoqing Inventor after: Yang Mengde Inventor after: Zhou Lina Inventor after: Hao Hongxun Inventor after: Wang Zhao Inventor after: Yin Qiuxiang Inventor before: Bao Ying Inventor before: Gao Zhenguo Inventor before: Hou Baohong Inventor before: Zhou Lina Inventor before: Hao Hongxun Inventor before: Wang Zhao Inventor before: Yin Qiuxiang Inventor before: Chen Wei Inventor before: Xie Chuang |